Table 2.
Scores of HDRS, FIM and SFE at Baseline, 12 months and 18 months
| Placebo (n=33) | Escitalopram (n=34) | Problem-Solving Therapy (n=41) | Test Results (Kruskal-Wallis test, χ2 (2)) | P value | |
|---|---|---|---|---|---|
| Mean (SD) | |||||
| HDRS score at baseline | 5.9 (2.8) | 7.1 (3.9) | 5.9 (2.9) | 2.02 | 0.3635 |
| --12 months | 5.0 (2.8) | 5.6 (3.3) | 4.7 (3.8) | 2.40 | 0.3010 |
| --18 months | 4.5 (2.3) | 6.9 (4.6) | 4.0 (2.9) | 10.05 | 0.0066 |
| FIM score at baseline | 117.4 (10.5) | 113.4 (18.6) | 113.0 (14.8) | 1.21 | 0.5468 |
| --12 months, | 121.6 (4.5) | 118.3 (11.6) | 121.6 (4.2) | 1.45 | 0.4837 |
| --18 months | 121.4 (4.5) | 117.4 (13.6) | 121.3 (4.7) | 3.38 | 0.1842 |
HDRS, Hamilton Depression Rating Scale; FIM, Functional Independence Measure.